US 12290551
Methods for imaging and treatment of somatostatin-receptor positive tumors
granted A61KA61K31/4745A61K38/31
Quick answer
US patent 12290551 (Methods for imaging and treatment of somatostatin-receptor positive tumors) held by Corcept Therapeutics Incorporated expires Mon May 01 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Corcept Therapeutics Incorporated
- Grant date
- Tue May 06 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 01 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K31/4745, A61K38/31, A61K45/06, A61K51/083